According to MRFR analysis, the global pharmaceutical sterility testing market is expected to register a CAGR of 6.6% from 2021 to 2027 and hold a value of USD 1,285.8 million by 2027. Sterility can ...
Researchers and therapeutic manufacturers have long relied on classical microbiological methods to check their samples and surfaces for microbial contamination, primarily using lengthy ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results